Skip to main content


Fig. 7 | Cancer & Metabolism

Fig. 7

From: Metabolomics of oncogene-specific metabolic reprogramming during breast cancer

Fig. 7

Metabolic profile of C3-TAg tumors. C3-TAg has lower metabolite levels in all pathways compared to other tumor groups, but still maintains higher levels of metabolites than normal mammary tissue. a Super pathway distributions of significantly up/downregulated metabolites in C3-TAg tumors compared to tumors of other transgenic mouse models and normal mammary tissue. b Decreased turnover of glutathione via the γ-glutamyl cycle in C3-TAg tumors compared to other tumors. *P < 0.05, Welch’s t test. Statistical comparisons were made between C3-TAg and every other sample group

Back to article page